Differences in Frontotemporal Dysfunction During Social and Non-social Cognition Tasks Between Patients with Autism Spectrum Disorder and Schizophrenia
Authors
Affiliations
Although literature evidence suggests deficits in social and non-social cognition in patients with autistic spectrum disorder (ASD) and schizophrenia (SCZ), the difference in neural correlates of the impairments between the two disorders has not been elucidated. We examined brain function in response to a non-social cognition and a social cognition task using functional near-infrared spectroscopy (fNIRS) in 13 patients with ASD, 15 patients with SCZ, and 18 healthy subjects. We assessed the brain function of participants using a verbal fluency task and an emotional facial recognition task. The patients with ASD showed significantly reduced brain activation in the left frontotemporal area during both tasks compared to healthy subjects. The patients with ASD with larger score in 'attention to detail' in the autism spectrum quotient showed lower activation of the left frontotemporal area during the two tasks. The patients with SCZ showed significantly reduced activation, compared to healthy subjects, and greater activation, compared to patients with ASD, in the area during the verbal fluency task. The patients with SCZ with more severe symptoms had lower brain activation during the task in this area. Our results suggest that two distinct areas are involved in the distinctive brain pathophysiology relevant to cognitive processing in patients with ASD and SCZ.
Sasaki J, Matsubara T, Chen C, Fujii Y, Fujita Y, Nakamuta M Front Psychiatry. 2023; 13:1048152.
PMID: 36683993 PMC: 9845941. DOI: 10.3389/fpsyt.2022.1048152.
Ren Y, Cui G, Zhang X, Feng K, Yu C, Liu P Front Psychiatry. 2022; 13:985076.
PMID: 36386968 PMC: 9640951. DOI: 10.3389/fpsyt.2022.985076.
Autism spectrum disorder and schizophrenia: An updated conceptual review.
Jutla A, Foss-Feig J, Veenstra-VanderWeele J Autism Res. 2021; 15(3):384-412.
PMID: 34967130 PMC: 8931527. DOI: 10.1002/aur.2659.
Ohtani T, Matsuo K, Sutoh C, Oshima F, Hirano Y, Wakabayashi A Neuropsychiatr Dis Treat. 2021; 17:3015-3024.
PMID: 34611402 PMC: 8487275. DOI: 10.2147/NDT.S327608.
fNIRS-derived neurocognitive ratio as a biomarker for neuropsychiatric diseases.
Akin A Neurophotonics. 2021; 8(3):035008.
PMID: 34604439 PMC: 8482313. DOI: 10.1117/1.NPh.8.3.035008.